Hamamatsu Pharma Research is a Japan-based preclinical CRO specializing in pharmacological efficacy studies using nonhuman primate (NHP) disease models. As nonhuman primates are phylogenetically and physiologically more similar to human than rodents, our NHP efficacy models will help you to obtain preclinical proof of concept (POC) relevant to clinical efficacy.
Hamamatsu Pharma Research is an AAALAC International accredited facility in JAPAN and creates exquisite NHP models, leveraging extensive experience in translational research and animal care. Develop your novel therapeutics with Hamamatsu Pharma research’s nonhuman primate efficacy models with higher efficacy.
Nonhuman primate (NHP) models deliver great value to your preclinical findings because of their genetic closeness to humans. NHPs, especially the macaque, are ideal for providing higher predictability of clinical efficacy of potential therapeutics than small animals such as rodents.
Other therapeutic areas available on request
Non-Human Primate Stroke Models
Non-Human Primate Pain-Related Models
Non-Human Primate Opthalmology Models
Dry age-related macular degeneration
Non-Human Primates Reproductive Disease Model
Non-Human Primate Model
Non-Human Primate Parkinson's Disease Model
NHP material for in vitro translational research
Nonhuman primates (cynomolgus macaque). The facility is located in Japan
Non-invasive in vivo imaging
Non-invasive imaging of NHPs reduces the number of animals required for a study and translates preclinical results to clinical outcomes.
Animal Model in vivo Analyses Services, using nonhuman primates (cynomolgus macaque)
Hamamatsu Pharma Research, Inc. has not received any reviews.
Hamamatsu Pharma Research, Inc. has not received any endorsements.